Illumina Launches fireflyGO Automation for MiSeq i100, Cuts Oncology Prep Time
ILMN•Illumina and SPT Labtech introduced the fireflyGO benchtop automation platform integrated with MiSeq i100 Series, reducing library preparation hands-on time and boosting reproducibility for targeted oncology research. The launch coincides with expanded Pillar Biosciences oncoReveal panels covering 84 genes for solid tumors and lymphoid malignancies, available worldwide.
1. Introduction of fireflyGO
Illumina and SPT Labtech have unveiled the fireflyGO benchtop automation platform designed for library preparation and liquid handling in targeted oncology research. The system seamlessly integrates with MiSeq i100 Series sequencers to streamline workflows and make next-generation sequencing more accessible to research laboratories.
2. Workflow Efficiency Gains
The fireflyGO platform automates manual touchpoints in library preparation, reducing hands-on time and minimizing staffing needs while enhancing reproducibility and reliability. Its compatibility with Pillar Biosciences oncoReveal targeted panels expands automation capabilities for a growing menu of oncology assays.
3. Expanded oncoReveal Panels
Illumina has broadened its oncoReveal portfolio with Nexus 21 and Lymphoid panels covering 84 genes across solid tumors like NSCLC, endometrial cancer and hematologic malignancies including AML, B-cell lymphoma and MPN. These panels are now available to customers worldwide, supporting rapid genomic characterization in cancer research.
